Health And Pharmaceutical - News from Health and Pharma Industry

Wockhardt Sep qtr net loss at Rs 54.20 cr

Pharmaceutical firm Wockhardt reported a consolidated net loss of Rs 54.20 crore for the quarter ended September 30.

Fortis Healthcare Q2 net up by 23%

Driven by robust growth in its larger units, hospital chain Fortis Healthcare reported a 23.4 per cent increase in net profit.

Tata Chemicals Q2 net profit at Rs 222.83 cr

Tata Chemicals reported a consolidated net profit of Rs 222.83 crore for Q2.

GSK Pharma Q3 profit rises 7%

GSK reported a rise of 7 per cent in net profit to Rs 141.08 crore.

GlaxoSmithKline Pharmaceuticals net sales up 12% in third quarter of FY 2009

GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September 2009.

Dabur Q2 net up 30.7%

Dabur India reported a 30.7% jump in consolidated net profit during second quarter.

Dr Reddy's Q2 net up 3 fold at Rs 240 cr

Pharma firm Dr Reddy's reported a near three-fold jump in its consolidated net profit at Rs 239.85 crore for the second quarter ended September 30, 2009.

India needs more provisions for basic health care: Amartya

India needs to invest more in providing basic health care services, especially in rural areas and backward states, noted economist and Nobel laureate Amartya Sen said in Mumbai.

Lenin died of syphilis, claims British historian

Syphilis killed Russian revolutionary Vladimir Lenin and not a stroke, believes a British historian.

Sun Pharma’s net dips 11% on US sales

Mumbai-based Sun Pharmaceuticals Industries Ltd has reported a 11% decline in its net profit for the second quarter ending September 30, 2009, on the back of lower sales revenue from the US market.

Pfizer posts 26% jump in Q3 profits

Global drug major Pfizer reported 26 per cent growth in third quarter profits at $2.89 bn.

Ranbaxy hails US court ruling on Valcyte patent

The Ranbaxy spokesperson declined to comment on the company's marketing plans after the ruling of the court.

Piramal Healthcare Q2 net up 45 pct

Piramal Helathcare reported 45 per cent jump in its consolidated net profit at Rs 106.27 crore for the second quarter ended September 30.

Pfizer forms policies to raise standards

To strengthen its position in conducting ethical clinical research activites, Pfizer India is developing open policies to improve the activities with better awareness levels along with ethical and high policy standards.

Lupin eyes $200 mn opportunity in US mkt

Lupin is gearing to tap opportunities to the tune of up to USD 200 million in the US.

Dabur expects input costs to surge in Q4

FMCG company Dabur expects input costs to surge in the fourth quarter of this fiscal.

Piramal Life Sciences net loss at Rs 31.47 cr

Drug research firm Piramal Life Sciences reported a net loss of Rs 31.47 crore.

EU anti-trust raid on Ranbaxy France unit

After facing a slew of troubles in the US market last year, the country’s largest drug maker, Ranbaxy Laboratories Ltd, in which Daiichi Sankyo of Japan has a 64% stake, is in for some rude shock in Europe.

Fortis shareholders approve 8 cr annual salary for MD

Fortis Healthcare said its shareholders have approved an annual pay package of up to Rs 8 crore for its Managing Director.

Ranbaxy to market Daiichi's products in Mexico

Ranbaxy Laboratories Ltd is going to market products from the portfolio of Japanese pharma firm Daiichi Sankyo in Mexico. The Gurgaon-based drug firm would market the products through its Latin America-based subsidiary, Ranbaxy Mexico SA de CV Mexico. Daiichi Sankyo holds around 64% stake in Ranbaxy.

Ranbaxy to sell Daiichi Sankyo’s products in Mexico

Ranbaxy Laboratories said it would market products from Daiichi Sankyo's portfolio in Mexico through its Latin America-based subsidiary, Ranbaxy Mexico S A de C V.

Latest News

Print Edition

Events